Session Details

[S7]Establishing Comprehensive Germline Analysis for Cancer Patients: A Roadmap from MGPT to WGS

Thu. Nov 19, 2026 4:00 PM - 6:00 PM JST
Thu. Nov 19, 2026 7:00 AM - 9:00 AM UTC
Room 3 (Exhibition Hall 1-B, Exhibition Building, Sendai International Center)
Chair: Takeshi Kuwata (National Cancer Center Hospital East), Makoto Hirata (National Cancer Center Hospital)
[English Session]

[S7-1]National Implementation of Cancer WGS: Advancement of the Action Plan for Whole Genome Sequencing

Ippei Fukada1,2 (1. Department of Patient-Centric Genomic Analytics, Genomic Medicine Japan, 2. Department of Genomic Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research)

[S7-2]Clinical Implementation of Cancer WGS in Japan: A Framework for Germline Findings

Arisa Ueki (Department of Clinical genetic Oncology, Cancer Institute Hospital for JFCR)

[S7-3]Maximizing Clinical Utility of Moderate-Penetrance Variants: Transitioning from Risk Assessment to Treatment Selection

Tomohiro Kondo1,2 (1. Department of Clinical Oncology, Kyoto University Hospital, 2. Real-World Data R&D, Graduate School of Medicine, Kyoto University)

[S7-4]Germline Profiling in Pediatric Oncology: Early Identification of Cancer Predisposition Syndromes and Long-term Benefits

Fumito Yamazaki (Department of Genetic Medicine and Services, National Cancer Center Hospital)

[S7-5]Cardiovascular Secondary Findings in Cancer WGS: From Variant Interpretation to Specialist Care

Yoshihiro Asano (National Cerebral and Cardiovascular Center)